MedPath
HSA Approval

ILDONG AMIKACIN INJECTION 500 mg/2 ml

SIN11944P

ILDONG AMIKACIN INJECTION 500 mg/2 ml

ILDONG AMIKACIN INJECTION 500 mg/2 ml

May 21, 2002

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01GB06

amikacin

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

IL-DONG PHARMACEUTICAL CO LTD

Active Ingredients

AMIKACIN SULFATE EQV AMIKACIN

500 mg/2 ml

Amikacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ILDONG AMIKACIN INJECTION 500 mg/2 ml - HSA Approval | MedPath